ACRUX LIMITED

3.45%

1.4¢

Market Cap $5.729M

Healthcare Drug Manufacturers - Specialty & Generic

Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is... Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist, Dapsone Gel, 5% and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto (estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.More

Neurizon's (ASX:NUZ) NUZ-001 OLE Study Demonstrates Long-Term Safety and Efficacy Signals

Latest Threads

Tag

Subject

ACR

Ann: Received $3.04m RDTI rebate for FY25

13/09/25

473

13/09/25

Last post mwilson25

473

ACR

Ann: Appendix 4E and Full Year Statutory Accounts FY25

03/09/25

1.5K

03/09/25

Last post nt_1973_au

1.5K

ACR

Ann: Appendix 4G and Corporate Governance Statement FY25

29/08/25

102

29/08/25

Last post

ASX News

102

ACR

Ann: Licensing partnership in Saudi Arabia for Dapsone 5%, Gel

04/08/25

3.1K

04/08/25

Last post mwilson25

3.1K

ACR

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

31/07/25

1.9K

31/07/25

Last post jetrodder

1.9K

ACR

Ann: Change in substantial holding

25/07/25

3.9K

25/07/25

Last post Furiousgeorge

3.9K

ACR

Ann: Receipt of second advance for FY25 R&D Tax Incentive

04/07/25

741

04/07/25

Last post Socrates2

741

ACR

Ann: Notification of cessation of securities - ACR

03/07/25

225

03/07/25

Last post

ASX News

225

See All Discussions

Timeline

Received $3.04m RDTI rebate for FY25
04 Sep 08:24	Share

Appendix 4G and Corporate Governance Statement FY25
29 Aug 08:58	Share

Appendix 4E and Full Year Statutory Accounts FY25
29 Aug 08:57	Share

Licensing partnership in Saudi Arabia for Dapsone 5%, Gel
31 Jul 09:01	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Jul 09:03	Share

Receipt of second advance for FY25 R&D Tax Incentive
03 Jul 09:29	Share

Notification of cessation of securities - ACR
03 Jul 09:24	Share

Application for quotation of securities - ACR
03 Jul 09:23	Share

Change in substantial holding
30 Jun 14:58	Share

App 3Z, Kotsanis
02 Jun 09:05	Share

App 3X, Warmbrunn
02 Jun 09:05	Share

Appendix 3Y Brumley
23 May 09:11	Share

Application for quotation of securities - ACR
23 May 09:10	Share

Notification of cessation of securities - ACR
23 May 09:05	Share

Dapsone 7.5%, Gel launched in the United States
09 May 08:33	Share

Acrux CEO and Managing Director appointment
07 May 09:12	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 10:03	Share

Details of Share Registry address
09 Apr 12:18	Share

Appendix 3Y Dobinson
04 Apr 09:11	Share

Application for quotation of securities - ACR
04 Apr 09:08	Share

Acrux receives $1.73m advance on FY25 R&D Tax Incentive
03 Apr 09:32	Share

Attaching Options final application date 31 March 2025
07 Mar 08:18	Share

Notification of cessation of securities - ACR
06 Mar 08:18	Share

Appendix 3Y Dobinson
04 Mar 08:19	Share

Cleansing Notice
03 Mar 17:29	Share

Application for quotation of securities - ACR
03 Mar 17:29	Share

Investor Presentation February 2025
25 Feb 16:54	Share

Investor Webinar Announcement
25 Feb 16:52	Share

Appendix 4D and December 2024 Half Year Accounts
25 Feb 16:50	Share

Top20 quoted option holders and distribution schedule
19 Feb 13:53	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.4¢		Change -0.001(3.45%)		Mkt cap ! $5.729M

Open	High	Low	Value	Volume
1.4¢	1.4¢	1.4¢	$1.923K	137.3K

Buyers (Bids)

No.	Vol.	Price($)
5	2317975	1.4¢

Sellers (Offers)

Price($)	Vol.	No.
1.5¢	905136	5

View Market Depth

No.	Vol.	Price($)
5	2317975	0.014
6	3270000	0.013
7	1793000	0.012
1	454545	0.011
6	1372500	0.010

Price($)	Vol.	No.
0.015	905136	5
0.016	385714	2
0.017	508041	2
0.018	560861	2
0.019	176000	2

Last trade - 10.10am 15/09/2025 (20 minute delay)


Last 1.5¢		Change -0.001 ( 7.14 %)
Open	High	Low	Volume
1.4¢	1.5¢	1.4¢	187609
Last updated 10.43am 15/09/2025 ?

ACR (ASX) Chart

ACRUX LIMITED

Latest Threads

Amaero’s big move: Exclusive deal, big targets, and a lot on the line

Timeline

Featured News

Latest Articles

Acrux scores fourth FDA approval, Nitroglycerin Ointment moving into commercialisation

Acrux Ltd has achieved the fourth approval from the US FDA, with its Nitroglycerin Ointment 0.4%, ready for commercialisation

US FDA approves review of Acrux (ASX:ACR) nitroglycerin ointment

Acrux (ASX:ACR) has received approval from the US FDA to review a generic version of its nitroglycerin ointment at 0.4 per cent concentration.

Acrux (ASX:ACR) announces buyout of future Lenzetto royalties

Pharmaceutical company Acrux (ACR) has reached an agreement for the EUR 4.10 million (A$6.41 million) buyout of future royalties for the company's Lenzetto product.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News